Tetrahydrocurcumin CAS: 36062-04-1

CAS NO: 36062-04-1
Tetrahydrocurcumin
Chemical Name: Tetrahydrocurcumin
Molecular Formula: C21H24O6
Formula Weight: 372.41
CAS No.: 36062-04-1
Description Review
Description

Tetrahydrocurcumin is a colorless derivative of curcumin, the bright yellow compound found in turmeric root. It has been studied for its potential health benefits, particularly in the areas of inflammation and oxidative stress.

Chemical name

The chemical name of tetrahydrocurcumin is (1E,4Z)-4-((1R,4aS,6R,8aS)-6-hydroxy-7-methyl-1,2,3,4,4a,5,6,7-octahydro-naphthalen-1-yl)-3-methoxyphenol.

Molecular Formula

The molecular formula of tetrahydrocurcumin is C21H24O6.

Formula weight

The formula weight of tetrahydrocurcumin is 372.41 g/mol.

CAS No.

The CAS number for tetrahydrocurcumin is 36062-04-1.

Top ten keywords from Google and Synonyms Synonym

  1. Curcumin
  2. Antioxidant
  3. Anti-inflammatory
  4. Natural remedy
  5. Traditional medicine
  6. Herbal supplement
  7. Skin health
  8. Liver health
  9. Diabetes
  10. Cardiovascular health

Synonyms: (1E,4Z)-4-((1R,4aS,6R,8aS)-6-hydroxy-7-methyl-1,2,3,4,4a,5,6,7-octahydro-naphthalen-1-yl)-3-methoxyphenol; THC.

Health benefits of this product

Tetrahydrocurcumin has been linked to several potential health benefits, primarily in the areas of inflammation, oxidative stress, and metabolic health. Specifically, it has been shown to possess potent antioxidant and anti-inflammatory properties, which may help protect against cellular damage and reduce inflammation in the body. Additionally, tetrahydrocurcumin has been studied for its potential to improve liver function, skin health, cardiovascular health, and blood glucose control.

Potential effects

Tetrahydrocurcumin works by modulating various signaling pathways involved in inflammation, oxidative stress, and metabolic health. For example, its antioxidant properties are thought to be due to its ability to scavenge free radicals, which can cause cellular damage and contribute to aging and disease. Additionally, its anti-inflammatory properties are thought to be due to its ability to inhibit the activity of inflammatory molecules in the body, such as cytokines and enzymes like cyclooxygenase-2 (COX-2). Finally, tetrahydrocurcumin has been shown to modulate various metabolic pathways involved in liver function, skin health, cardiovascular health, and blood glucose control.

Product mechanism

The mechanism of action of tetrahydrocurcumin is through its modulation of various signaling pathways involved in inflammation, oxidative stress, and metabolic health. For example, it scavenges free radicals, which can cause cellular damage and contribute to aging and disease. Additionally, it inhibits the activity of inflammatory molecules in the body, such as cytokines and COX-2. Finally, tetrahydrocurcumin has been shown to modulate various metabolic pathways involved in liver function, skin health, cardiovascular health, and blood glucose control.

Safety

Tetrahydrocurcumin is generally considered safe when taken at recommended doses. However, high doses may cause gastrointestinal upset or interact with certain medications, such as blood thinners. Pregnant women should also exercise caution when taking tetrahydrocurcumin, as its safety in pregnancy has not been established.

Side effects

Some studies have reported mild side effects associated with tetrahydrocurcumin supplementation, including gastrointestinal upset and headache. These side effects have generally been transient and self-limited and have not been associated with any serious adverse events to date.

Dosing information

The optimal dosing regimen for tetrahydrocurcumin depends on the specific condition being treated and individual patient factors. Doses typically range from 500 mg to 2 g per day, with adjustments made based on patient response and tolerability.

Conclusion

Tetrahydrocurcumin is a colorless derivative of curcumin that has several potential health benefits, particularly in the areas of inflammation, oxidative stress, and metabolic health. While more research is needed to fully understand its safety and efficacy in humans, tetrahydrocurcumin shows promise as a potential therapeutic option for individuals with a variety of health conditions

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code